The US Food and Drug Administration (FDA) issued a advisory statement warning the public against the use of hyperbaric oxygen therapy (HBOT) for Autism 22 August 2013. The action, which also notes concern about other unproven uses of HBOT, apparently was predicated on the FDA’s receipt of multiple complaints from consumers, and it is consistent with long-standing concerns about this therapy that I have raised here on EBD Blog: 17 October 2008, 21 March 2009, 17 August 2009, 12 November 2009, 18 November 2009, 21 November 2009.
Tag Archive for 'hbot'
Doreen Granpeesheh and colleagues reported that a randomized trial of hyperbaric-oxygen therapy did not produce beneficial effects on children with Autism. The results of the study—double-blind, placebo controlled procedures, making it scientifically sound—showed no significant differences in direct observations of toy play, hyperactivity, appropriate vocalizations, vocal stereotypy, physical stereotypy, aggression, self-injury, property destruction or on standardized assessment employing a host of psychological measures.
Continue reading ‘More reason to doubt benefits of HBOT’